North Bethesda, MD, United States of America

Raffaello Cimbro

This inventor holds 1 USPTO granted patent. Top assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2017.


Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2017

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Raffaello Cimbro: Innovator in HIV Therapeutics

Introduction

Raffaello Cimbro is a notable inventor based in North Bethesda, MD (US). He has made significant contributions to the field of HIV therapeutics, focusing on innovative methods for treatment and prevention of HIV-1 infections. His work is crucial in the ongoing battle against this global health challenge.

Latest Patents

Cimbro holds 1 patent related to HIV therapeutics. His patent, titled "HIV therapeutics and methods of making and using same," discloses HIV neutralizing peptides, sulfated HIV-1 envelope proteins, and immunogenic fragments. The patent also includes nucleic acids encoding these molecules and methods for producing them. The methods provided can include administering these HIV neutralizing peptides or proteins to generate an immune response in subjects.

Career Highlights

Cimbro's career is marked by his dedication to advancing medical science, particularly in the area of HIV research. He works for the United States of America, as represented by the Secretary, Department of Health and Human Services. His innovative approaches have the potential to change the landscape of HIV treatment.

Collaborations

Cimbro collaborates with esteemed professionals in his field, including Paolo Lusso. Their combined expertise enhances the research and development of effective HIV therapies.

Conclusion

Raffaello Cimbro's contributions to HIV therapeutics exemplify the impact of innovation in medicine. His work not only advances scientific understanding but also offers hope for improved treatment options for those affected by HIV.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…